Table 2.

Risk factors for invasive aspergillosis in SOT recipients. Herbrecht et al. [13] have listed the general risk factors for invasive fungal infections in haemato-oncological patients and solid organ transplant recipients, but the list is continuously increasing, and presently includes a number of additional factors [14–16], among them influenza, [17, 18]

	Risk factors	References
Heart	Reoperation; CMV infection; post-transplantation hemodialysis; presence of another patient with IA in the transplant program 2 months before or after the procedure; rejection, admission to the ICU, mechanical ventilation, and extracorporeal membrane oxygenation (ECMO)	[19, 20]
Kidney	Bloodstream infections; pre-transplant chronic pulmonary obstructive disease; impaired graft function; long-term dialysis prior to transplantation; serious post-transplant infections	[21, 22]
Liver	MELD score, choledochojejunostomy; anastomosis; bacterial infections in the first month and absence of antifungal prophylaxis; cytomegalovirus (CMV) reactivation; renal failure; hemodialysis; re-transplantation or transplantation for fulminant hepatic failure; reoperation	[5, 12, 22–24]
Lung	Single lung transplantation; pre- and post-transplant colonization with Aspergillus spp., early airway ischemia, CMV infection, rejection	[25, 26]